$PVBC
Provident Bancorp Inc (Maryland) Stock $pvbc

$pvbc Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000177878421000012 Filed on March 26, 2021

Income Statement

Concept	2019 Q4	2019 Q3	2019 Q2
Revenue	$13.36M	$13.32M	$12.73M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$430.0K	$190.0K	$370.0K
YoY Change	152.94%	5.56%	105.56%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$1.788M	$2.259M	$2.130M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$3.400M	$4.804M	$3.420M
YoY Change	-10.76%	70.35%	5.88%
Income Tax	$849.0K	$1.295M	$889.0K
% Of Pretax Income	24.97%	26.96%	25.99%
Net Earnings	$2.551M	$3.509M	$2.531M
YoY Change	-10.18%	68.7%	5.9%
Net Earnings / Revenue	19.09%	26.35%	19.88%
Basic Earnings Per Share	$0.15	$0.19	$0.14
Diluted Earnings Per Share	$0.15	$0.19	$0.14
COMMON SHARES
Basic Shares Outstanding	18.01M	18.79M	18.76M
Diluted Shares Outstanding	18.14M	18.97M	18.90M

Balance Sheet

Concept	2019 Q4	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$59.66M	$38.97M	$28.28M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$14.73M	$24.10M	$22.80M
YoY Change	-8.52%	61.74%	59.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.200M	$6.300M	$6.400M
YoY Change	12.5%	18.87%	23.08%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.122B	$1.078B	$1.031B
YoY Change	15.16%	17.83%	11.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$3.900M	$3.900M	$3.900M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.900M	$3.900M	$3.900M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$12.10M	$11.40M	$10.10M
YoY Change	-2.42%	-2.56%	-10.62%
Total Long-Term Liabilities	$12.10M	$11.40M	$10.10M
YoY Change	-2.42%	-2.56%	-10.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.900M	$3.900M	$3.900M
Total Long-Term Liabilities	$12.10M	$11.40M	$10.10M
Total Liabilities	$890.9M	$942.5M	$899.4M
YoY Change	4.99%	18.85%	11.66%
SHAREHOLDERS EQUITY
Retained Earnings	$94.16M
YoY Change
Common Stock	$195.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$230.9M	$135.9M	$131.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.122B	$1.078B	$1.031B
YoY Change	15.16%	17.83%	11.43%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	$2.551M	$3.509M	$2.531M
YoY Change	-10.18%	68.7%	5.9%
Depreciation, Depletion And Amortization	$430.0K	$190.0K	$370.0K
YoY Change	152.94%	5.56%	105.56%
Cash From Operating Activities	$6.150M	$7.000M	$1.910M
YoY Change	31.41%	82.77%	-62.55%
INVESTING ACTIVITIES
Capital Expenditures	-$1.080M	-$1.470M	-$1.750M
YoY Change	-18.18%	86.08%	660.87%
Acquisitions
YoY Change
Other Investing Activities	-$23.41M	-$36.73M	-$25.76M
YoY Change	-57.64%	204.06%	198.84%
Cash From Investing Activities	-$24.48M	-$38.21M	-$27.50M
YoY Change	-56.74%	196.89%	210.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	39.02M	41.90M	30.15M
YoY Change	-28.46%	-427.86%	3.15%
NET CHANGE
Cash From Operating Activities	6.150M	7.000M	1.910M
Cash From Investing Activities	-24.48M	-38.21M	-27.50M
Cash From Financing Activities	39.02M	41.90M	30.15M
Net Change In Cash	20.69M	10.69M	4.560M
YoY Change	686.69%	-148.99%	-82.1%
FREE CASH FLOW
Cash From Operating Activities	$6.150M	$7.000M	$1.910M
Capital Expenditures	-$1.080M	-$1.470M	-$1.750M
Free Cash Flow	$7.230M	$8.470M	$3.660M
YoY Change	20.5%	83.33%	-31.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001778784
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-39090
CY2020	dei	Entity Registrant Name EntityRegistrantName	PROVIDENT BANCORP, INC
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-4132422
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Market Street
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Amesbury
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01913
CY2020	dei	City Area Code CityAreaCode	978
CY2020	dei	Local Phone Number LocalPhoneNumber	834-8555
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2020	dei	Trading Symbol TradingSymbol	PVBC
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	134400000
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19014660
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	11830000
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	11990000
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	71989000
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	47668000
CY2020Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	83819000
CY2019Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	59658000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	32215000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	41790000
CY2020Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	895000
CY2019Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	1416000
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	18518000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	13844000
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1314810000
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	959286000
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	36684000
CY2019Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	26925000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14716000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14728000
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	6371000
CY2019Q4	us-gaap	Interest Receivable InterestReceivable	2854000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4258000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3713000
CY2020Q4	us-gaap	Other Assets OtherAssets	12013000
CY2019Q4	us-gaap	Other Assets OtherAssets	11418000
CY2020Q4	us-gaap	Assets Assets	1505781000
CY2019Q4	us-gaap	Assets Assets	1121788000
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	383079000
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	222088000
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	854349000
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	627817000
CY2020Q4	us-gaap	Deposits Deposits	1237428000
CY2019Q4	us-gaap	Deposits Deposits	849905000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	13500000
CY2019	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	51538000
CY2020	us-gaap	Interest Expense Deposits InterestExpenseDeposits	5203000
CY2019	us-gaap	Interest Expense Deposits InterestExpenseDeposits	6258000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	24998000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4488000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3877000
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	14509000
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	12075000
CY2020Q4	us-gaap	Liabilities Liabilities	1269925000
CY2019Q4	us-gaap	Liabilities Liabilities	890855000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19047544
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19047544
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19473818
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19473818
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	191000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	195000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	139450000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	146174000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	104508000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	94159000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1058000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	458000
CY2020Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	9351000
CY2019Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	10053000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	235856000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	230933000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1505781000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1121788000
CY2020	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	59391000
CY2019	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	49693000
CY2020	us-gaap	Interest And Dividend Income Securities InterestAndDividendIncomeSecurities	913000
CY2019	us-gaap	Interest And Dividend Income Securities InterestAndDividendIncomeSecurities	1549000
CY2020	pvbc	Interest Income From Short Term Investments InterestIncomeFromShortTermInvestments	99000
CY2019	pvbc	Interest Income From Short Term Investments InterestIncomeFromShortTermInvestments	296000
CY2020	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	60403000
CY2020	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	728000
CY2019	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1890000
CY2020	us-gaap	Interest Expense InterestExpense	5931000
CY2019	us-gaap	Interest Expense InterestExpense	8148000
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	54472000
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	43390000
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	5597000
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	5326000
CY2020	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	48875000
CY2019	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	38064000
CY2020	pvbc	Customer Service Fees On Deposit Accounts CustomerServiceFeesOnDepositAccounts	1331000
CY2019	pvbc	Customer Service Fees On Deposit Accounts CustomerServiceFeesOnDepositAccounts	1452000
CY2020	pvbc	Service Charges And Fees Other ServiceChargesAndFeesOther	1322000
CY2019	pvbc	Service Charges And Fees Other ServiceChargesAndFeesOther	1783000
CY2019	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	113000
CY2020	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	809000
CY2019	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	699000
CY2020	us-gaap	Other Income OtherIncome	81000
CY2019	us-gaap	Other Income OtherIncome	64000
CY2020	us-gaap	Noninterest Income NoninterestIncome	3543000
CY2019	us-gaap	Noninterest Income NoninterestIncome	4111000
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	23175000
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	18243000
CY2020	us-gaap	Occupancy Net OccupancyNet	1684000
CY2019	us-gaap	Occupancy Net OccupancyNet	1968000
CY2020	us-gaap	Equipment Expense EquipmentExpense	577000
CY2019	us-gaap	Equipment Expense EquipmentExpense	444000
CY2020	pvbc	Deposit Insurance DepositInsurance	416000
CY2019	pvbc	Deposit Insurance DepositInsurance	203000
CY2020	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1000000
CY2019	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	826000
CY2020	us-gaap	Marketing Expense MarketingExpense	223000
CY2019	us-gaap	Marketing Expense MarketingExpense	385000
CY2020	us-gaap	Professional Fees ProfessionalFees	1868000
CY2019	us-gaap	Professional Fees ProfessionalFees	1210000
CY2020	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	750000
CY2019	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	741000
CY2020	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	959000
CY2019	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	734000
CY2020	pvbc	Write Down Of Other Assets And Receivables Investing Activities WriteDownOfOtherAssetsAndReceivablesInvestingActivities	2207000
CY2020	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2949000
CY2019	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2802000
CY2020	us-gaap	Noninterest Expense NoninterestExpense	35808000
CY2019	us-gaap	Noninterest Expense NoninterestExpense	27556000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16610000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14619000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4625000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3811000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11985000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	10808000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18090229
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17958186
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18131025
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18066968
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11985000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	10808000
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	805000
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1070000
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	113000
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	805000
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	957000
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	205000
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	244000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	600000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	713000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12585000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11521000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	125584000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	10808000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	713000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	999000
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	91578000
CY2019	pvbc	Adjustments To Additional Paid In Capital Capital Contributions AdjustmentsToAdditionalPaidInCapitalCapitalContributions	372000
CY2019	pvbc	Shares Surrendered During Period Value Related To Tax Withholdings On Restricted Stock Awards SharesSurrenderedDuringPeriodValueRelatedToTaxWithholdingsOnRestrictedStockAwards	193000
CY2019	pvbc	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Ownership Plan Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockOwnershipPlanRequisiteServicePeriodRecognition	1072000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	230933000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11985000
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.03
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1636000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	600000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1089000
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	7825000
CY2020	pvbc	Shares Surrendered During Period Value Related To Tax Withholdings On Restricted Stock Awards SharesSurrenderedDuringPeriodValueRelatedToTaxWithholdingsOnRestrictedStockAwards	131000
CY2020	pvbc	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Ownership Plan Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockOwnershipPlanRequisiteServicePeriodRecognition	841000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	235856000
CY2019Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2.0212
CY2020	us-gaap	Net Income Loss NetIncomeLoss	11985000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	10808000
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-266000
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-218000
CY2020	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	841000
CY2019	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1072000
CY2019	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	113000
CY2020	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-2023000
CY2019	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-989000
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	5597000
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	5326000
CY2020	pvbc	Depreciation Depletion And Amortization Including Leases DepreciationDepletionAndAmortizationIncludingLeases	1091000
CY2019	pvbc	Depreciation Depletion And Amortization Including Leases DepreciationDepletionAndAmortizationIncludingLeases	1391000
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9000
CY2020	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	3267000
CY2019	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	216000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2202000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1049000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1089000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	999000
CY2020	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	809000
CY2019	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	699000
CY2019	pvbc	Increase Decrease In Sale Of Other Real Estate Owned IncreaseDecreaseInSaleOfOtherRealEstateOwned	138000
CY2020	pvbc	Principal Repayments Of Operating Lease Liabilities PrincipalRepaymentsOfOperatingLeaseLiabilities	82000
CY2019	pvbc	Principal Repayments Of Operating Lease Liabilities PrincipalRepaymentsOfOperatingLeaseLiabilities	61000
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	785000
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	810000
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2434000
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-200000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18181000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17508000
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	13729000
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	13565000
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10114000
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10629000
CY2020	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-521000
CY2019	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-1234000
CY2020	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	296472000
CY2019	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	124358000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	66962000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	911000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6245000
CY2019	pvbc	Additions To Other Real Estate Owned AdditionsToOtherRealEstateOwned	64000
CY2019	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	85000
CY2020	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	8950000
CY2019	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	1878000
CY2019	pvbc	Cash Received From Provident Bancorp CashReceivedFromProvidentBancorp	372000
CY2020	pvbc	Write Down Of Other Assets And Receivables Investing Activities WriteDownOfOtherAssetsAndReceivablesInvestingActivities	2207000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-360453000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-116633000
CY2020	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	160991000
CY2019	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	84787000
CY2020	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	226532000
CY2019	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	-2978000
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	1636000
CY2019	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-38024000
CY2020	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	11498000
CY2019	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	5000000
CY2020	pvbc	Shares Surrendered Related To Tax Withholdings On Restricted Stock Awards SharesSurrenderedRelatedToTaxWithholdingsOnRestrictedStockAwards	131000
CY2019	pvbc	Shares Surrendered Related To Tax Withholdings On Restricted Stock Awards SharesSurrenderedRelatedToTaxWithholdingsOnRestrictedStockAwards	193000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7825000
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	91578000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	366433000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	130170000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	24161000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	31045000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59658000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28613000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83819000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59658000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	5932000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	8148000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	6264000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	5008000
CY2020	pvbc	Recognition Of Right Of Use Assets In Premises And Equipment RecognitionOfRightOfUseAssetsInPremisesAndEquipment	693000
CY2019	pvbc	Recognition Of Right Of Use Assets In Premises And Equipment RecognitionOfRightOfUseAssetsInPremisesAndEquipment	3836000
CY2020	pvbc	Recognition Of Operating Lease Liabilities RecognitionOfOperatingLeaseLiabilities	693000
CY2019	pvbc	Recognition Of Operating Lease Liabilities RecognitionOfOperatingLeaseLiabilities	3938000
CY2019	pvbc	Reclassification Of Accrued Rent From Other Liabilities To Premises And Equipment ReclassificationOfAccruedRentFromOtherLiabilitiesToPremisesAndEquipment	102000
CY2019	pvbc	Loan Originated From Sale Of Premises And Equipment LoanOriginatedFromSaleOfPremisesAndEquipment	6455000
CY2019	pvbc	Transfer To Other Estate TransferToOtherEstate	740000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3000
CY2020	us-gaap	Nature Of Operations NatureOfOperations	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">NOTE 1 — NATURE OF OPERATIONS</span><span id="Notes" style="text-decoration: none;"/><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Provident Bancorp, Inc. (the “Company”) </span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">is a Maryland corporation that was incorporated in June 2019 to be the successor corporation to Provident Bancorp, Inc. (“Old Provident”), a Massachusetts corporation, upon completion of the second-step mutual-to-stock conversion (the “Conversion”) of Provident Bancorp (the “MHC”), the top tier mutual holding company of Old Provident. Old Provident was the former mid-tier holding company for The Provident Bank (“BankProv” or the “Bank”). Prior to completion of the Conversion, approximately </span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">52</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of the shares of common stock of Old Provident were owned by the MHC. In conjunction with the Conversion, the MHC was merged into the Company (and ceased to exist) and the Company became its successor under the name Provident Bancorp, Inc. The Conversion was completed on October 16, 2019. The Company raised gross proceeds of $</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">102.1</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million by selling </span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10,212,397</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock at $</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10.00</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per share in the second-step stock offering. The Company utilized $</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">8.2</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million of the proceeds to lend to its Employee Stock Ownership Plan (the “ESOP”) for the acquisition of an additional </span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">816,992</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares at $</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10.00</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per share. Expenses incurred related to the offering were $</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2.4</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million, and have been recorded against offering proceeds. The Company invested $</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">45.8</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million of the net proceeds it received from the sale into the Bank’s operations and has retained the remaining amount for general corporate purposes. Concurrent with the completion of the stock offering, each share of Old Provident common stock owned by public stockholders (stockholders other than the MHC) was exchanged for </span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2.0212</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of Company common stock. A total of </span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">19,484,343</span><span style="white-space:pre-wrap; color: #242021;font-family: TimesNRMTPro;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock were outstanding following the completion of the stock offering.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Bank, headquartered in Amesbury, Massachusetts, operates its business from </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">seven</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> banking offices located in Amesbury and Newburyport, Massachusetts and Portsmouth, Exeter, Bedford, and Seabrook, New Hampshire. The Bank also has loan production offices in Boston, Massachusetts and Ponte Vedra, Florida. The Bank provides a variety of financial services to small businesses and individuals. Its primary deposit products are checking, savings and term certificate accounts and its primary lending products are commercial mortgages, commercial loans and mortgage warehouse loans.</span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span>
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19484343
CY2020	pvbc	Number Of Banking Offices NumberOfBankingOffices	7
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Use of Estimates</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">To prepare financial statements in conformity with GAAP management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ.</span></p>
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Significant Concentrations of Credit Risk</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The primary lending area for the includes Northeastern Massachusetts and Southern New Hampshire, with a focus on Essex County, Massachusetts, and Hillsborough and Rockingham Counties, New Hampshire, which are part of, and bedroom communities to, the technology corridor between Boston, Massachusetts and Concord, New Hampshire. In 2018, the Bank started offering its enterprise value loan product nationally. In 2020, the Bank purchased a warehouse lending business which is located in Ponte Vedra, Florida and targets national credit worthy, small to mid-cap non-bank mortgage origination companies for facility lines. The primary deposit-gathering area is currently concentrated in Essex County, Massachusetts, and Rockingham County and Hillsborough County, New Hampshire. The Company believes that it does not have any significant loan concentrations or investment securities in any one industry or with any customer.</span></p>
CY2020	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Reclassification</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts in the prior year have been reclassified to be consistent with the current year's consolidated financial statement presentation, and the reclassifications had no effect on the net income reported in the consolidated income statement.</span></p>
CY2020	pvbc	Par Value Of Stock Bought From And Sold To Federal Home Loan Bank ParValueOfStockBoughtFromAndSoldToFederalHomeLoanBank	100
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	30815000
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1410000
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	10000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	32215000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	41195000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	666000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	71000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	41790000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	919000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	963000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	912000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	917000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	8380000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	9014000
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	30815000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	32215000
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0
CY2020	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0
CY2019	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	216000
CY2019	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	103000
CY2020Q4	pvbc	Securities Of Issuers Whose Aggregate Carrying Amount Exceeded Threshold Percentage SecuritiesOfIssuersWhoseAggregateCarryingAmountExceededThresholdPercentage	0
CY2020Q4	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	21300000
CY2019Q4	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	30600000
CY2020Q4	pvbc	Debt Securities Available For Sale Total Number Of Positions DebtSecuritiesAvailableForSaleTotalNumberOfPositions	56
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	3
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	817000
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	10000
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	817000
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	10000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	5813000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	12000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	5418000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	59000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	11231000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	71000
CY2020Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1337563000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	975342000
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	18518000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	13844000
CY2020Q4	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	4235000
CY2019Q4	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	2212000
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1314810000
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	959286000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	13844000
CY2020	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	1089000
CY2020	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	166000
CY2020	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	5597000
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	18518000
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	2024000
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	16494000
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	18518000
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	25659000
CY2020Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1311904000
CY2020Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1337563000
CY2018Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	11680000
CY2019	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	3305000
CY2019	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	143000
CY2019	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	5326000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	13844000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1682000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12162000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	13844000
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	24663000
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	950679000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	975342000
CY2020Q4	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	360500000
CY2019Q4	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	450600000
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	6426000
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1331137000
CY2020Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1337563000
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5419000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	23268000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	952074000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	975342000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5827000
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	21635000
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	21915000
CY2020	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	21996000
CY2020	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	377000
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	4024000
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	4605000
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	2024000
CY2020	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	4177000
CY2020	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	1000
CY2020Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	25659000
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	26520000
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	2024000
CY2020	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	26173000
CY2020	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	378000
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	3765000
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	4174000
CY2019	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	5043000
CY2019	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	101000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	20898000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	21006000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1682000
CY2019	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	21893000
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	24663000
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	25180000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1682000
CY2019	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	26936000
CY2019	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	101000
CY2020	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	10
CY2020	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	18892000
CY2020	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	20392000
CY2019	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	2
CY2019	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	2640000
CY2019	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	2640000
CY2020	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	10
CY2020	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	10
CY2020	pvbc	Impairment Analysis Performed And Specific Reserve ImpairmentAnalysisPerformedAndSpecificReserve	157000
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	23300000
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	4200000
CY2020Q4	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2020Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1337563000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	975342000
CY2018Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	11957000
CY2019	us-gaap	Loans And Leases Receivable Related Parties Additions LoansAndLeasesReceivableRelatedPartiesAdditions	5303000
CY2019	pvbc	Loans And Leases Receivable Related Parties Principal Payments LoansAndLeasesReceivableRelatedPartiesPrincipalPayments	-13555000
CY2019Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	3705000
CY2019Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	3705000
CY2020	us-gaap	Loans And Leases Receivable Related Parties Additions LoansAndLeasesReceivableRelatedPartiesAdditions	12329000
CY2020	pvbc	Loans And Leases Receivable Related Parties Principal Payments LoansAndLeasesReceivableRelatedPartiesPrincipalPayments	-656000
CY2020Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	15378000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25086000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24234000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10370000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9506000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14716000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14728000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	944000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1200000
CY2020Q4	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	554095000
CY2019Q4	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	369423000
CY2020Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	151341000
CY2019Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	115593000
CY2020Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	353793000
CY2019Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	270471000
CY2020Q4	us-gaap	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW	1059229000
CY2019Q4	us-gaap	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW	755487000
CY2020Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	5167000
CY2019Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	15575000
CY2020Q4	pvbc	Time Deposits Less Than250000 TimeDepositsLessThan250000	173032000
CY2019Q4	pvbc	Time Deposits Less Than250000 TimeDepositsLessThan250000	78843000
CY2020Q4	us-gaap	Time Deposits TimeDeposits	178199000
CY2019Q4	us-gaap	Time Deposits TimeDeposits	94418000
CY2020Q4	us-gaap	Deposits Deposits	1237428000
CY2019Q4	us-gaap	Deposits Deposits	849905000
CY2020Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	114100000
CY2019Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	48600000
CY2020Q4	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	139794000
CY2020Q4	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	36161000
CY2020Q4	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	897000
CY2020Q4	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	175000
CY2020Q4	us-gaap	Time Deposit Maturities Year Five TimeDepositMaturitiesYearFive	1172000
CY2020Q4	us-gaap	Time Deposits TimeDeposits	178199000
CY2020Q4	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	8800000
CY2019Q4	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	7800000
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	11498000
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5000000
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8500000
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8500000
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	5000000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	13500000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	24998000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4906000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3477000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1928000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1392000
CY2020	pvbc	Net Operating Loss Carryforward NetOperatingLossCarryforward	7000
CY2019	pvbc	Net Operating Loss Carryforward NetOperatingLossCarryforward	9000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6827000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4860000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1525000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-724000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-677000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-325000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2202000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1049000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4625000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3811000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.060
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.058
CY2020	pvbc	Effective Income Tax Rate Reconciliation Tax Exempt Income Percent And Dividends Received Deduction EffectiveIncomeTaxRateReconciliationTaxExemptIncomePercentAndDividendsReceivedDeduction	-0.004
CY2019	pvbc	Effective Income Tax Rate Reconciliation Tax Exempt Income Percent And Dividends Received Deduction EffectiveIncomeTaxRateReconciliationTaxExemptIncomePercentAndDividendsReceivedDeduction	-0.006
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.012
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.278
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.261
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	5132000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	3837000
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	71000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2849000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2707000
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1174000
CY2019Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	613000
CY2020Q4	pvbc	Deferred Tax Assets Write Down Other Assets And Receivables DeferredTaxAssetsWriteDownOtherAssetsAndReceivables	111000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	37000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	31000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	344000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	164000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9647000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7430000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5000
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	60000
CY2019Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	43000
CY2019Q4	pvbc	Deferred Tax Liabilities Fhlb Restructure Fees DeferredTaxLiabilitiesFhlbRestructureFees	8000
CY2020Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	342000
CY2019Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	137000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	407000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	188000
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	9240000
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7242000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3463
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3115
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y6M
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y6M
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0104
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0066
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0183
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.79
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.80
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11985000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10808000
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	19422096
CY2019	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	19511700
CY2020	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	1207892
CY2019	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	1345983
CY2020	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	123975
CY2019	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	152682
CY2019	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	54849
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18090229
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17958186
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	40796
CY2019	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	108782
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18131025
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18066968
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	73399
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14298
CY2020Q4	pvbc	Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.00045
CY2020Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.060
CY2020Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.080
CY2020Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.040
CY2020Q4	pvbc	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.00065
CY2020Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.080
CY2020Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.10
CY2020Q4	pvbc	Tier One Leverage Ratio TierOneLeverageRatio	0.050
CY2020	pvbc	Capital Conservation Buffer Above Required Capital Ratios CapitalConservationBufferAboveRequiredCapitalRatios	0.025
CY2020Q4	pvbc	Community Bank Leverage Ratio To Be Well Capitalized To Weighted Assets CommunityBankLeverageRatioToBeWellCapitalizedToWeightedAssets	0.08
CY2020Q4	pvbc	Community Bank Leverage Ratio To Be Well Capitalized To Weighted Assets CommunityBankLeverageRatioToBeWellCapitalizedToWeightedAssets	0.08
CY2020Q4	us-gaap	Capital Capital	199377000
CY2020Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1460
CY2020Q4	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	109273000
CY2020Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.080
CY2020Q4	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	136591000
CY2020Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.100
CY2020Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	182286000
CY2020Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1335
CY2020Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	81955000
CY2020Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.060
CY2020Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	109273000
CY2020Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.080
CY2020Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	182286000
CY2020Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.1335
CY2020Q4	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	61466000
CY2020Q4	pvbc	Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.00045
CY2020Q4	us-gaap	Common Equity Tier One Capital Required To Be Well Capitalized CommonEquityTierOneCapitalRequiredToBeWellCapitalized	88784000
CY2020Q4	pvbc	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.00065
CY2020Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	182286000
CY2020Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.1237
CY2020Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	58926000
CY2020Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.040
CY2020Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	73658000
CY2020Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.050
CY2019Q4	us-gaap	Capital Capital	181135000
CY2019Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1762
CY2019Q4	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	82238000
CY2019Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.080
CY2019Q4	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	102798000
CY2019Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.100
CY2019Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	168273000
CY2019Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1637
CY2019Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	61679000
CY2019Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.060
CY2019Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	82238000
CY2019Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.080
CY2019Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	168273000
CY2019Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.1637
CY2019Q4	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	46259000
CY2019Q4	pvbc	Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.00045
CY2019Q4	us-gaap	Common Equity Tier One Capital Required To Be Well Capitalized CommonEquityTierOneCapitalRequiredToBeWellCapitalized	66819000
CY2019Q4	pvbc	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.00065
CY2019Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	168273000
CY2019Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.1518
CY2019Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	44352000
CY2019Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.040
CY2019Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	55440000
CY2019Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.050
CY2020Q4	us-gaap	Statutory Accounting Practices Statutory Amount Available For Dividend Payments Without Regulatory Approval StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval	12100000
CY2019Q4	us-gaap	Statutory Accounting Practices Statutory Amount Available For Dividend Payments Without Regulatory Approval StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval	10700000
CY2018Q4	us-gaap	Statutory Accounting Practices Statutory Amount Available For Dividend Payments Without Regulatory Approval StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval	9300000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4300000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3700000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4500000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3900000
CY2020	pvbc	Number Of Branch Locations NumberOfBranchLocations	2
CY2020	pvbc	Number Of Leased Loan Production Offices NumberOfLeasedLoanProductionOffices	1
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	307000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	375000
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0354
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0378
CY2019Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P20Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P27Y7M6D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P31Y10M24D
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	258000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	261000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	264000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	270000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	280000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	6325000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7658000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3170000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4488000
CY2020Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	235617000
CY2019Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	232772000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	32215000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	41790000
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2000000
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2020000
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	14089000
CY2019Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	12129000
CY2020Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	14654000
CY2019Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	12731000
CY2020Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	15178000
CY2019Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	13316000
CY2020Q4	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16482000
CY2019Q4	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	13362000
CY2020Q1	us-gaap	Interest Expense InterestExpense	2017000
CY2019Q1	us-gaap	Interest Expense InterestExpense	1971000
CY2020Q2	us-gaap	Interest Expense InterestExpense	1619000
CY2019Q2	us-gaap	Interest Expense InterestExpense	2130000
CY2020Q3	us-gaap	Interest Expense InterestExpense	1183000
CY2019Q3	us-gaap	Interest Expense InterestExpense	2259000
CY2020Q4	us-gaap	Interest Expense InterestExpense	1112000
CY2019Q4	us-gaap	Interest Expense InterestExpense	1788000
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12072000
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10158000
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13035000
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10601000
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13995000
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11057000
CY2020Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15370000
CY2019Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11574000
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3099000
CY2019Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1462000
CY2020Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	872000
CY2019Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1354000
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	760000
CY2019Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	833000
CY2020Q4	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	866000
CY2019Q4	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1677000
CY2019Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	113000
CY2020Q1	pvbc	Other Income Without Gain On Sale Of Securities OtherIncomeWithoutGainOnSaleOfSecurities	1010000
CY2019Q1	pvbc	Other Income Without Gain On Sale Of Securities OtherIncomeWithoutGainOnSaleOfSecurities	933000
CY2020Q2	pvbc	Other Income Without Gain On Sale Of Securities OtherIncomeWithoutGainOnSaleOfSecurities	704000
CY2019Q2	pvbc	Other Income Without Gain On Sale Of Securities OtherIncomeWithoutGainOnSaleOfSecurities	1056000
CY2020Q3	pvbc	Other Income Without Gain On Sale Of Securities OtherIncomeWithoutGainOnSaleOfSecurities	911000
CY2019Q3	pvbc	Other Income Without Gain On Sale Of Securities OtherIncomeWithoutGainOnSaleOfSecurities	1040000
CY2020Q4	pvbc	Other Income Without Gain On Sale Of Securities OtherIncomeWithoutGainOnSaleOfSecurities	918000
CY2019Q4	pvbc	Other Income Without Gain On Sale Of Securities OtherIncomeWithoutGainOnSaleOfSecurities	969000
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	1010000
CY2019Q1	us-gaap	Noninterest Income NoninterestIncome	1046000
CY2020Q2	us-gaap	Noninterest Income NoninterestIncome	704000
CY2019Q2	us-gaap	Noninterest Income NoninterestIncome	1056000
CY2020Q3	us-gaap	Noninterest Income NoninterestIncome	911000
CY2019Q3	us-gaap	Noninterest Income NoninterestIncome	1040000
CY2020Q4	us-gaap	Noninterest Income NoninterestIncome	918000
CY2019Q4	us-gaap	Noninterest Income NoninterestIncome	969000
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	8306000
CY2019Q1	us-gaap	Noninterest Expense NoninterestExpense	6746000
CY2020Q2	us-gaap	Noninterest Expense NoninterestExpense	8361000
CY2019Q2	us-gaap	Noninterest Expense NoninterestExpense	6883000
CY2020Q3	us-gaap	Noninterest Expense NoninterestExpense	9686000
CY2019Q3	us-gaap	Noninterest Expense NoninterestExpense	6460000
CY2020Q4	us-gaap	Noninterest Expense NoninterestExpense	9455000
CY2019Q4	us-gaap	Noninterest Expense NoninterestExpense	7466000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	446000
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	778000
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1256000
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	889000
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1258000
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1295000
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1665000
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	849000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1231000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	2218000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	3250000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	2531000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	3202000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	3509000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	4302000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	2551000
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18115970
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18730676
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18150106
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18758735
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18185995
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18786692
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17912975
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18006471
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18261282
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18807840
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18179858
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18895918
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18222766
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18965924
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18007580
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18135220

Files In Submission

Name	View Source	Status
0001778784-21-000012-index-headers.html	Edgar Link	pending
0001778784-21-000012-index.html	Edgar Link	pending
0001778784-21-000012.txt	Edgar Link	pending
0001778784-21-000012-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pvbc-20201231.xsd	Edgar Link	pending
pvbc-20201231x10k.htm	Edgar Link	pending
pvbc-20201231x10k_htm.xml	Edgar Link	completed
pvbc-20201231xex23_1.htm	Edgar Link	pending
pvbc-20201231xex23_2.htm	Edgar Link	pending
pvbc-20201231xex31_1.htm	Edgar Link	pending
pvbc-20201231xex31_2.htm	Edgar Link	pending
pvbc-20201231xex32.htm	Edgar Link	pending
pvbc-20201231_cal.xml	Edgar Link	unprocessable
pvbc-20201231_def.xml	Edgar Link	unprocessable
pvbc-20201231_lab.xml	Edgar Link	unprocessable
pvbc-20201231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PVBC
Provident Bancorp Inc (Maryland) Stock $pvbc

2019 Q4 Form 10-K Financial Statement

#000177878421000012 Filed on March 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PVBC Provident Bancorp Inc (Maryland) Stock $pvbc

2019 Q4 Form 10-K Financial Statement

#000177878421000012 Filed on March 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PVBC
Provident Bancorp Inc (Maryland) Stock $pvbc